-+ 0.00%
-+ 0.00%
-+ 0.00%

After the US Food and Drug Administration lifted the hold on a clinical trial of an antidepressant, GH Research's stock soared 44% in the premarket.

Zhitongcaijing·01/05/2026 13:33:30
Listen to the news
After the US Food and Drug Administration lifted the hold on a clinical trial of an antidepressant, GH Research's stock soared 44% in the premarket.